Saskia Luelmo

1.8k citations
30 papers · 380 · h-index 12

Impact in

  • Oncology
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Screening and Detection
    • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

  • Oncology 20
    • Pancreatic and Hepatic Oncology Research 15
    • Colorectal Cancer Treatments and Studies 2
  • Pulmonary and Respiratory Medicine 7
    • Renal cell carcinoma treatment 2
    • Prostate Cancer Treatment and Research 2
    • Gastric Cancer Management and Outcomes 2
Co-authors
Bert A. Bonsing (11 shared papers)J. Sven D. Mieog (8 shared papers)Thomas P. Potjer (5 shared papers)Hans F. A. Vasen (6 shared papers)Akin Inderson (6 shared papers)Martin N.J.M. Wasser (4 shared papers)Shirin Feshtali (6 shared papers)Friedo W. Dekker (3 shared papers)
Journals
Journal of Clinical Oncology (5 papers)Cancers (2 papers)Journal of Clinical Pathology (2 papers)Pancreatology (1 paper)Thrombosis Research (1 paper)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

Saskia Luelmo

29 papers receiving 378 citations

Peers

Saskia Luelmo
Comparison fields: 5 of 53
  • Oncology 196
  • Cancer Research 84
  • Internal Medicine 10
  • Critical Care and Intensive Care Medicine 10
  • Pathology and Forensic Medicine 28
Replace Ersin Özaslan with:
Ersin Özaslan Türkiye
John M. Richart United States
S.B. Kim South Korea
Shang‐Yin Wu Taiwan
Sema Sezgin Göksu Türkiye
Carmelina Rodinò Italy
Jui‐Ho Wang Taiwan
Xianlan Zhao China
Santhalingam Jegatheeswaran United Kingdom
Saskia Luelmo relative to Ersin Özaslan Türkiye Ersin Özaslan's profile →
Citations per field
00.5×2×4×6×
Ersin Özaslan · 1×
Citations per year

Countries citing papers authored by Saskia Luelmo

Since Specialization
Citations

This map shows the geographic impact of Saskia Luelmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia Luelmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia Luelmo more than expected).

Fields of papers citing papers by Saskia Luelmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia Luelmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia Luelmo. The network helps show where Saskia Luelmo may publish in the future.

Co-authors

The 25 scholars most cited alongside Saskia Luelmo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saskia Luelmo Line = papers co-authored together Saskia Luelmo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up
Journal of Clinical Oncology ·Derk C.F. Klatte, Bas Boekestijn, Martin N.J.M. Wasser, Shirin Feshtali Shahbazi, Isaura S. Ibrahim, J. Sven D. Mieog, Saskia Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Friedo W. Dekker, Hans F. A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
202264
2
No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: A randomized, placebo-controlled study
Critical Care Medicine ·Hens Bouter, Emile F. Schippers, Saskia Luelmo, M. I. M. Versteegh, Peter Ros, H. F. L. Guiot, Marijke Frölich, Jaap T. van Dissel
200241
3
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Gastroenterology ·Derk C.F. Klatte, Bas Boekestijn, Anke Onnekink, Friedo W. Dekker, Lydia G. van der Geest, Martin N.J.M. Wasser, Shirin Feshtali, J. Sven D. Mieog, Saskia Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Hans F. A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
202339
4
The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study)
Clinical Pharmacology & Therapeutics ·Floor J.E. Lubberman, Hans Gelderblom, Paul Hamberg, Walter L. Vervenne, Sasja F. Mulder, Frank G. A. Jansman, Angela Colbers, Winette T.A. van der Graaf, David M. Burger, Saskia Luelmo, Dirk Jan A. R. Moes, Carla M.L. van Herpen, Nielka P. van Erp
201930
5
Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer
Journal of Clinical Pathology ·Babs G. Sibinga Mulder, J. Sven D. Mieog, Henricus J.M. Handgraaf, Arantza Fariña Sarasqueta, Hans F. A. Vasen, Thomas P. Potjer, Rutger‐Jan Swijnenburg, Saskia Luelmo, Shirin Feshtali, Akin Inderson, Alexander L. Vahrmeijer, Bert A. Bonsing, Tom van Wezel, Hans Morreau
201623
6
Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy
Cancers ·Martijn A. van Dam, Floris A. Vuijk, Judith A. Stibbe, Ruben D. Houvast, Saskia Luelmo, Stijn Crobach, Shirin Feshtali, Lioe‐Fee de Geus‐Oei, Bert A. Bonsing, Cornelis F.M. Sier, Peter J.K. Kuppen, Rutger‐Jan Swijnenburg, Albert D. Windhorst, Jacobus Burggraaf, Alexander L. Vahrmeijer, J. Sven D. Mieog
202118
7
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
Frontiers in Immunology ·Fleur van der Sijde, Willem A. Dik, Dana A. M. Mustafa, Eveline E. Vietsch, Marc G. Besselink, Reno Debets, Bas Groot Koerkamp, Brigitte C.M. Haberkorn, Marjolein Y.V. Homs, Quisette P. Janssen, Saskia Luelmo, Leonie J. Mekenkamp, Astrid A. M. Oostvogels, Marja A. W. Smits-te Nijenhuis, Johanna W. Wilmink, Casper H.J. van Eijck, (unknown)
202215
8
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
International Journal of Molecular Sciences ·Fleur van der Sijde, Marjolein Y.V. Homs, Marlies L. van Bekkum, Thierry van den Bosch, Koop Bosscha, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Thomas M. Karsten, Bas Groot Koerkamp, Brigitte C.M. Haberkorn, Saskia Luelmo, Leonie J. Mekenkamp, Dana A. M. Mustafa, Johanna W. Wilmink, Casper H.J. van Eijck, Eveline E. Vietsch, (unknown)
202115
9
Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer
Thrombosis Research ·R.G. Hanna-Sawires, Jesse V. Groen, Alexander Hamming, Rob A.�E.�M. Tollenaar, Wilma E. Mesker, Saskia Luelmo, Alexander L. Vahrmeijer, Bert A. Bonsing, Henri H. Versteeg, Frederikus A. Klok, J. Sven D. Mieog
202115
10
Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival
Annals of Surgery ·Freek R. van ‘t Land, Mohammad H. Aziz, Nynke Michiels, J. Sven D. Mieog, Bert A. Bonsing, Saskia Luelmo, Marjolein Y.V. Homs, Bas Groot Koerkamp, Grigorios Papageorgiou, Casper H.J. van Eijck
202315
11
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
Therapeutic Advances in Medical Oncology ·Fleur van der Sijde, Zakia Azmani, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Bas Groot Koerkamp, Brigitte C.M. Haberkorn, Marjolein Y.V. Homs, Wilfred F. J. van IJcken, Quisette P. Janssen, Martijn P. Lolkema, Saskia Luelmo, Leonie J. Mekenkamp, Dana A. M. Mustafa, Ron H. N. van Schaik, Johanna W. Wilmink, Eveline E. Vietsch, Casper H.J. van Eijck
202113
12
Remission of psoriasis during treatment with sorafenib
JAAD Case Reports ·Marloes S. van Kester, Saskia Luelmo, Maarten H. Vermeer, Christian U. Blank, Remco van Doorn
201811
13
Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers
European Journal of Human Genetics ·Isaura S. Ibrahim, Babs G. Sibinga Mulder, Bert A. Bonsing, Hans Morreau, Arantza Fariña Sarasqueta, Akin Inderson, Saskia Luelmo, Shirin Feshtali, Thomas P. Potjer, Wouter de Vos tot Nederveen Cappel, Martin N.J.M. Wasser, Hans F. A. Vasen
20189
14
Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer
Journal of Clinical Pathology ·Babs G. Sibinga Mulder, J. Sven D. Mieog, Arantza Fariña Sarasqueta, Henricus J.M. Handgraaf, Hans F. A. Vasen, Rutger‐Jan Swijnenburg, Saskia Luelmo, Shirin Feshtali, Akin Inderson, Alexander L. Vahrmeijer, Bert A. Bonsing, Tom van Wezel, Hans Morreau
20179
15
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients
European Journal of Radiology ·Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Saskia Luelmo, Renske Spijkerman, Jelle J. Goeman, Frank Toonen, Frits Smit, Tom van der Hulle, Linda Heijmen
20249
16
Identifying the Need to Discuss Infertility Concerns Affecting Testicular Cancer Patients: An Evaluation (INDICATE Study)
Cancers ·Esmée M. Krouwel, Thijs Jansen, Melianthe P. J. Nicolai, Sandra Dieben, Saskia Luelmo, Hein Putter, Rob C.M. Pelger, Henk W. Elzevier
20218
17
The self-perceived palliative care barriers and educational needs of clinicians working in hospital primary care teams and referral patterns: lessons learned from a single-center survey and cohort study
Annals of Palliative Medicine ·Lotte van der Stap, Ellen J. M. de Nijs, M.J.M. Oomes, Carla C. M. Juffermans, Willeke M Ravensbergen, Saskia Luelmo, Nanda Horeweg, Yvette M. van der Linden
20217
18
Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies
The Oncologist ·Feng Jung Sherida H. Woei-A-Jin, Shu Zhen Zheng, Inci Kiliçsoy, Francisca Hudig, Saskia Luelmo, Judith R. Kroep, Hildo J. Lamb, Susanne Osanto
20196
19
The prognostic value of the 12‐, 6‐, 3‐ and 1‐month ‘Surprise Question’ in cancer patients: A prospective cohort study in three hospitals
European Journal of Cancer Care ·Arianne Brinkman‐Stoppelenburg, Müzeyyen Arslan, Catherine Owusuaa, Nicolette Gunnink, Yvette M. van der Linden, Saskia Luelmo, Jetske Meerum‐Terwogt, Annemieke van der Padt‐Pruijsten, Daan Nieboer, Agnes van der Heide
20226
20
The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis
HPB ·Tara M. Mackay, Willemieke P.M. Dijksterhuis, Anouk E.J. Latenstein, Lydia G. van der Geest, Mirjam A. G. Sprangers, Casper H.J. van Eijck, Marjolein Y.V. Homs, Saskia Luelmo, I. Quintus Molenaar, Hjalmar van Santvoort, Jennifer M. J. Schreinemakers, Johanna W. Wilmink, Marc G. Besselink, Hanneke W. M. van Laarhoven, Martijn G.H. van Oijen
20216

About Saskia Luelmo

Saskia Luelmo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Public Health, Environmental and Occupational Health and Cancer Research, having authored 30 papers that have together received 380 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Prostate Cancer Treatment and Research (2 papers), Palliative Care and End-of-Life Issues (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (196 citations), Cancer Research (84 citations), Internal Medicine (10 citations), Critical Care and Intensive Care Medicine (10 citations) and Pathology and Forensic Medicine (28 citations). Saskia Luelmo has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Bert A. Bonsing, J. Sven D. Mieog, Thomas P. Potjer, Hans F. A. Vasen, Akin Inderson, Martin N.J.M. Wasser, Shirin Feshtali, Friedo W. Dekker, Monique E. van Leerdam and Derk C.F. Klatte. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Journal of Clinical Pathology, Pancreatology and Thrombosis Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ersin ÖzaslanBreakdown of academic impact, for papers by John M. RichartBreakdown of academic impact, for papers by S.B. KimBreakdown of academic impact, for papers by Shang‐Yin WuBreakdown of academic impact, for papers by Sema Sezgin GöksuBreakdown of academic impact, for papers by Carmelina RodinòBreakdown of academic impact, for papers by Jui‐Ho WangBreakdown of academic impact, for papers by Xianlan ZhaoBreakdown of academic impact, for papers by Santhalingam Jegatheeswaran